AlainHRookMD

Professor of Dermatology, University Pennsylvania

Dr. Rook is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
University of Pennsylvania, 3400 Civic Center Blvd.
1-Perelman South
Philadelphia, PA 19104
Phone+1 215-662-7610

Fax+1 215-615-4966

Dr. Alain Rook is a dermatologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. He received his medical degree from University of Michigan Medical School and has been in practice 42 years. He is experienced in general dermatology, cryosurgery, phototherapy, and complex medical dermatology. He has more than 300 publications and over 500 citings.

University of Pennsylvania Health SystemResidency, Dermatology, 1986 - 1989
National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1984 - 1986
McGill UniversityFellowship, Nephrology, 1977 - 1979
McGill University Residency, Internal Medicine, 1975 - 1977
University of Michigan Medical SchoolClass of 1975

Philadelphia Magazine Castle Connolly, 2004-2014
America's Top Doctors Castle Connolly, 2004-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Fellow (FAAD) American Academy of Dermatology
Join now to see all

PubMed

Journal Articles

Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome
Paul L Haun, Sara S Samimi, Alain H Rook, Ellen J Kim, JAMA Dermatology
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome
Ellen J Kim, Carmela Vittorio, Paul L Haun, Sara S Samimi, Rachael A Clark, Alain H Rook, JAMA Dermatology

Lectures

Management Issues in Cutaneous Lymphoma
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Other

Clinical presentation, pathologic features, and diagnosis of S??zary syndrome
Rook AH, Olsen EA
http://www.uptodate.com/contents/clinical-presentation-pathologic-features-and-diagnosis-of-sezary-s
UpToDate, Wolters Kluwer Health - 2013-02-05

'Chromosomal Chaos:' Complex Array of Mutations Found in Rare, Aggressive LeukemiaOctober 7th, 2015
Triple Therapy Regime Puts Patients with Leukemic Form of Cutaneous Lymphoma in RemissionAugust 19th, 2011

Toll Receptor Ligand Therapy Of Cutaneous T-Cell LymphomaNational Cancer Institute2008–2011
Immunotherapy Of Cutaneous T-Cell Lymphoma With Interleukin-12National Cancer Institute2007–2008
Dendritic Cell Defects In Cutaneous T-Cell LymphomaNational Cancer Institute2003–2007
Immunotherapy Of Cutaneous T-Cell Lymphoma WNational Cancer Institute2004–2006
Recombinant Interleukin-12 For Cutaneous T-Cell LymphomaNational Cancer Institute2001–2006
Recombinant Human IL-12 In Mycosis FungoidesNational Center For Research Resources2004–2005
Cytokine Therapy Of Cutaneous T Cell LymphomaNational Cancer Institute2000–2004
Effects Of Interleukin 12 In Cutaneous T Cell LymphomaNational Cancer Institute2001–2002
Recombinant Interleukin 12 In Patients W/ Stage IA, IB Of IIA MycosisNational Center For Research Resources1999–2002
Interleukin 12 Therapy Of Cutaneous T Cell LymphomaNational Cancer Institute1999–2000
Recombinant Human Interleukin 12 In Cutaneous T Cell LymphomaNational Center For Research Resources1997–2000
Photophoresis With Liquid 8-Methoxsalen In Systemic SclerosisNational Center For Research Resources1996–2000
Abnormal Cytokine Syntheses In Cutaneous T-Cell LymphomaNational Cancer Institute1993–1995